Filing Details
- Accession Number:
- 0001593968-20-000988
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-03 17:07:17
- Reporting Period:
- 2020-04-01
- Accepted Time:
- 2020-04-03 17:07:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1771917 | Karuna Therapeutics Inc. | KRTX | Pharmaceutical Preparations (2834) | 270605902 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1777760 | Craig Andrew Miller | 33 Arch St Ste 3110 Boston MA 02110-1424 | Chief Operating Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-04-01 | 10,654 | $2.92 | 10,654 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-04-01 | 10,654 | $64.37 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-04-01 | 14,346 | $7.27 | 14,346 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-04-01 | 14,346 | $64.37 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Karuna Therapeutics, Inc. Common Stock | Option (right to buy) | Disposition | 2020-04-01 | 10,654 | $0.00 | 10,654 | $2.92 |
Karuna Therapeutics, Inc. Common Stock | Option (right to buy) | Disposition | 2020-04-01 | 14,346 | $0.00 | 14,346 | $7.27 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
142,917 | 2016-07-18 | 2026-10-12 | No | 4 | M | Direct |
92,796 | 2018-09-15 | 2028-08-09 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.